RECENT NEWS
MedPage Today  Jun 25  Comment 
(MedPage Today) -- As federal regulators have been drawing up new rules for the 340B drug discount program, a pitched battle has broken out between hospitals and drug manufacturers who say the program is now bloated and badly regulated.
Reuters  Mar 26  Comment 
REUTERS - spate of regulatory warnings for India's generic drug manufacturers will add a new emphasis on the quality of such medicines in an industry long dominated by the ability to deliver treatments as cheaply as possible, analysts say.
The Hindu Business Line  Feb 11  Comment 
The US Food and Drug Administration (US FDA) is looking at speeding up its process of approvals. This will help speed up the backlog of inspections for Indian drug manufacturers who have applied f...
MedPage Today  Aug 6  Comment 
(MedPage Today) -- Patients with diabetic macular edema who received aflibercept (Eylea) showed greater improvement in vision than those treated with a laser procedure, the drug's manufacturers said.
TheStreet.com  Jul 18  Comment 
By S.Z. Berg NEW YORK (MainStreet)--The Food and Drug Administration (FDA) announced a proposal to revise drug labeling regulations for generic drugs to create parity among brand name and generic drug manufacturers. The revised rule would allow...
New York Times  Jul 16  Comment 
Rising Chinese demand for drugs is a boon for foreign companies, but bribery allegations against GlaxoSmithKline underscore the risk of scrutiny from officials.     
Sydney Morning Herald  Jul 5  Comment 
Drug manufacturers supplying to China will reportedly face investigation into their pricing practices as the government takes action on rising living costs.     
MedPage Today  Apr 24  Comment 
WASHINGTON (MedPage Today) -- The FDA has expanded the indications for oral lubiprostone (Amitiza) to include constipation in chronic pain patients taking opioids, according to the drug's manufacturers.
Reuters  Apr 2  Comment 
The United States said on Tuesday it was considering its response to the Supreme Court ruling that U.S. drug manufacturers warn is the latest sign of a "deteriorating" environment for intellectual property rights in the country.
The Hindu Business Line  Mar 2  Comment 
Besides catering to leading generic drug manufacturers globally, the company has tapped into the innovators’ market too.




Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki